BackTakeda Pharmaceutical Company Limited Overview
Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited P/E Ratio

Latest P/E ratio for Takeda Pharmaceutical Company Limited: 28.29 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

28.29

P/E Ratio

28.29

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Takeda Pharmaceutical Company Limited (TKPHF) FAQ

Takeda Pharmaceutical Company Limited posts a P/E ratio of 28.29. That is above the Healthcare sector average of 21.65. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a P/E ratio near 21.65 is typical. Takeda Pharmaceutical Company Limited's 28.29 is higher that level. That is roughly 30.7% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Takeda Pharmaceutical Company Limited's P/E ratio of 28.29 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for TKPHF's P/E ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.65), and (3) consistency with growth and profitability. This page covers the first two; Takeda Pharmaceutical Company Limited's other metric pages and overview cover the third.

Judging Takeda Pharmaceutical Company Limited against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in P/E ratio easier to interpret. Start with 28.29 here, then scan peer and history charts to see if the gap is persistent.